Physician profile
Robert Adams
NPI 1447207436
$321,008.60
in general payments reported to CMS, 2019-2025
29 companies · $42K in 2025
The $42K reported for 2025 was more than what 97% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $32K · 2021: $67K · 2022: $45K · 2023: $53K · 2024: $52K · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $92K · Travel and Lodging: $24K · Consulting Fee: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $4,873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $92,350.00 |
| Travel and Lodging | $24,102.77 |
| Consulting Fee | $12,719.59 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,550.00 |
| Food and Beverage | $4,873.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $293,432.03 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Medtronic, INC. | $19,608.78 | 2021-2024 | Signia, Mosaic, Sonicision |
| Ethicon US, LLC | $2,847.90 | 2022-2025 | Echelon Flex, Echelon; Endopath, Echelon Endopath |
| Ethicon INC. | $1,755.00 | 2021 | |
| Atricure, INC. | $989.30 | 2019-2025 | Synergy Ablation System |
| Ethicon Endo-Surgery INC. | $400.00 | 2025 | Echelon Flex |
| Abiomed | $310.91 | 2019-2024 | Impella |
| Davol INC. | $273.20 | 2024-2025 | Progel Applicator Spray Tips |
| Covidien Lp | $270.65 | 2019-2020 | |
| Galvanize Therapeutics, INC | $183.86 | 2023-2025 | Aliya System |
| Smith+Nephew, INC. | $161.01 | 2024 | Stravix, Pico 14 |
| Merck Sharp & Dohme LLC | $149.85 | 2023-2025 | Keytruda |
| Edwards Lifesciences Corporation | $111.82 | 2021-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.79 | 2019-2024 | Jardiance |
| Zimmer Biomet Holdings, INC. | $65.59 | 2019-2023 | Advantagerib |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lsi Solutions INC | $65.38 | 2019-2023 | Cor Knot |
| Abbott Laboratories | $50.04 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Irhythm Technologies, INC. | $38.84 | 2023 | Zio Xt Patch |
| Bayer Healthcare Pharmaceuticals INC. | $30.79 | 2022-2023 | |
| Astrazeneca Pharmaceuticals Lp | $27.11 | 2024 | |
| Medtronic Vascular, INC. | $24.59 | 2020 | |
| Kerecis Limited | $23.58 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Acera Surgical, INC. | $20.47 | 2024 | Restrata Wound Matrix |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.25 | 2024 | Lifevest |
| Baxter Healthcare | $17.64 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $15.26 | 2022 | |
| United Therapeutics Corporation | $14.43 | 2019 | |
| Amgen INC. | $14.25 | 2025 | Repatha |
| Janssen Pharmaceuticals, INC | $12.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.